Clinical Trial Update: First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

This update announces the first-in-human Phase 1/2 trial of STUP-001, an in vivo direct cell conversion gene therapy, for chronic spinal cord injury (AIS-A/B), …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• STUP-001

Snippet

Sponsor: Yonsei University | Conditions: Spinal Cord Injury, Chronic Spinal Cord Injury | Phase 1, Phase 2 | Status: RECRUITING